-
Health-related Quality of life, Financial Toxicity, Productivity Loss and Catastrophic Health Expenditures After Lung Cancer Diagnosis in Argentina
Authors:
Lucas Gonzalez,
Andrea Alcaraz,
Carolina Gabay,
Monica Castro,
Silvina Vigo,
Eduardo Carinci,
Federico Augustovski
Abstract:
Objective: About 12,000 people are diagnosed with lung cancer (LC) each year in Argentina, and the diagnosis has a significant personal and family. The objective of this study was to characterize the Health-Related Quality of Life (HRQoL) and the economic impact in patients with LC and in their households. Methods: Observational cross-sectional study, through validated structured questionnaires to…
▽ More
Objective: About 12,000 people are diagnosed with lung cancer (LC) each year in Argentina, and the diagnosis has a significant personal and family. The objective of this study was to characterize the Health-Related Quality of Life (HRQoL) and the economic impact in patients with LC and in their households. Methods: Observational cross-sectional study, through validated structured questionnaires to patients with a diagnosis of Non-Small Cell Lung Cancer (NSCLC) in two referral public health care centers in Argentina. Questionnaries used: Health-Related Quality of life (EuroQol EQ-5D-3L questionnaire); financial toxicity (COST questionnaire); productivity loss (WPAI-GH, Work Productivity and Activity Impairment Questionnaire: General Health), and out-of-pocket expenses. Results: We included 101 consecutive patients (mean age 67.5 years; 55.4% men; 57.4% with advanced disease -stage III/IV-). The mean EQ-VAS was 68.8 (SD:18.3), with 82.2% describing fair or poor health. The most affected dimensions were anxiety/depression, pain, and activities of daily living. Patients reported an average 59% decrease in their ability to perform regular daily activities as measured by WPAI-GH. 54.5% reported a reduction in income due to the disease, and 19.8% lost their jobs. The annual economic productivity loss was estimated at USD 2,465 per person. 70.3%) of patients reported financial toxicity. The average out-of-pocket expenditure was USD 100.38 per person per month, which represented 18.5% of household income. Catastrophic expenditures were present in 37.1% of households. When performing subgroup analysis by disease severity, all outcomes were worse in the subpopulation with advanced disease. Conclusions Patients with NSCLC treated in public hospitals in Argentina have significant health-related quality of life and economic impact, worsening in patients with advanced disease.
△ Less
Submitted 27 December, 2023;
originally announced December 2023.
-
Lung Cancer in Argentina: A Modelling Study of Disease and Economic Burden
Authors:
Andrea Alcaraz,
Federico Rodriguez Cairoli,
Carla Colaci,
Constanza Silvestrini,
Carolina Gabay,
Natalia Espinola
Abstract:
Objectives: Lung cancer remains a significant global public health challenge and is still one of the leading cause of cancer-related death in Argentina. This study aims to assess the disease and economic burden of lung cancer in the country.
Study design: Burden of disease study
Methods. A mathematical model was developed to estimate the disease burden and direct medical cost attributable to l…
▽ More
Objectives: Lung cancer remains a significant global public health challenge and is still one of the leading cause of cancer-related death in Argentina. This study aims to assess the disease and economic burden of lung cancer in the country.
Study design: Burden of disease study
Methods. A mathematical model was developed to estimate the disease burden and direct medical cost attributable to lung cancer. Epidemiological parameters were obtained from local statistics, the Global Cancer Observatory, the Global Burden of Disease databases, and a literature review. Direct medical costs were estimated through micro-costing. Costs were expressed in US dollars (US$), April 2023 (1 US$ =216.38 argentine pesos). A second-order Monte Carlo simulation was performed to estimate the uncertainty.
Results: Considering approximately 10,000 deaths, 12,000 incident cases, and 14,000 5-year prevalent cases, the economic burden of lung cancer in Argentina in 2023 was estimated to be US$ 556.20 million (396.96 -718.20), approximately 1.4% of the total healthcare expenditure for the country. The cost increased with a higher stage of the disease and the main driver was the drug acquisition (80%). 179,046 Disability-adjusted life years could be attributable to lung cancer representing the 10% of the total cancer.
Conclusion: The disease and economic burden of lung cancer in Argentina implies a high cost for the health system and would represent 19% of the previously estimated economic burden for 29 cancers in Argentina.
△ Less
Submitted 10 October, 2023;
originally announced October 2023.
-
Automatic selection by penalized asymmetric Lq-norm in an high-dimensional model with grouped variables
Authors:
Angelo Alcaraz,
Gabriela Ciuperca
Abstract:
The paper focuses on the automatic selection of the grouped explanatory variables in an high-dimensional model, when the model errors are asymmetric. After introducing the model and notations, we define the adaptive group LASSO expectile estimator for which we prove the oracle properties: the sparsity and the asymptotic normality.
Afterwards, the results are generalized by considering the asymme…
▽ More
The paper focuses on the automatic selection of the grouped explanatory variables in an high-dimensional model, when the model errors are asymmetric. After introducing the model and notations, we define the adaptive group LASSO expectile estimator for which we prove the oracle properties: the sparsity and the asymptotic normality.
Afterwards, the results are generalized by considering the asymmetric $L_q$-norm loss function. The theoretical results are obtained in several cases with respect to the number of variable groups. This number can be fixed or dependent on the sample size $n$, with the possibility that it is of the same order as $n$. Note that these new estimators allow us to consider weaker assumptions on the data and on the model errors than the usual ones. Simulation study demonstrates the competitive performance of the proposed penalized expectile regression, especially when the samples size is close to the number of explanatory variables and model errors are asymmetrical. An application on air pollution data is considered.
△ Less
Submitted 11 March, 2022;
originally announced March 2022.
